Saama

Saama is a healthcare and life sciences focused investor with a strong operational heritage in clinical data and AI. The firm backs early-stage companies at Seed, Pre-Series A, and Series A with cheque sizes typically ranging from $1M to $10M. What sets Saama apart is its deep domain expertise in life sciences data workflows, clinical trials, and AI-driven healthcare applications, giving portfolio founders access to industry knowledge and networks that go well beyond capital. Saama is particularly relevant for founders building at the intersection of AI and healthcare, including clinical intelligence, drug discovery, real-world evidence, and health data infrastructure. For Indian founders, Saama represents a partner that understands both the scientific complexity of life sciences and the commercial path to global markets, especially given the strong India-US corridor in pharma and clinical research outsourcing. Founders should expect a thesis-aligned partner who can open doors with global pharmaceutical companies, biotech players, and research institutions. If your startup is using data and AI to solve meaningful problems in healthcare or life sciences, Saama is worth approaching with a clear articulation of your scientific differentiation and commercialization roadmap.